Formuepleje A/S’s Ambev ABEV Stock Holding History

Formuepleje A/S’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-293,220	Closed	-$1.79M	–	80
2015 Q2	$1.79M	Hold	293,220	–	–	0.21%	34
2015 Q1	$1.69M	Buy	293,220 +79,750	+37%	+$495K	0.2%	32
2014 Q4	$1.33M	Buy	+213,470	New	+$1.35M	0.17%	32

Other funds holding ABEV

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.8B AUM 25.03% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

GTP

Global Thematic Partners New York $120M AUM 25.18% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Formuepleje A/S's ABEV Position: Q3 2015 in Review

Formuepleje A/S sold out of Ambev (ABEV) in Q3 2015, closing a stake of 293,220 shares — an estimated $1.79M sold.

Formuepleje A/S first reported a position in ABEV in Q4 2014 and held it in 3 quarters. The position peaked at $1.79M in Q2 2015. 301 funds tracked by Wall St. Rank hold ABEV as of Q3 2015.

Formuepleje A/S reported no remaining Ambev position as of Q3 2015 after selling out during the quarter.
Formuepleje A/S sold 293,220 Ambev shares in Q3 2015, an estimated $1.79M.
Formuepleje A/S first reported a position in Ambev in Q4 2014 and held it in 3 quarters.
Formuepleje A/S's Ambev position peaked at $1.79M in Q2 2015.
301 funds tracked by Wall St. Rank held Ambev as of Q3 2015.

Based on Formuepleje A/S's 13F filing for Q3 2015, filed 27 Aug 2026.